Serum hyaluronic acid as a marker of hepatic fibrosis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 17, Issue 6, 2007, Pages 323-326

  Khan, Mohammad Jawwad Anis ^a   Khan, Farooq Ahmad ^b   Dilawar, Muhamamd ^b   Ijaz, Aamir ^b   Khan, Nadeem Akbar ^b   Mehmood, Tariq ^b  

^a CMH   (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

Chronic liver disease; Hepatic fibrosis; Hyaluronic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOCHEMICAL MARKER; HYALURONIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; STAGING;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 34548283433     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cell in fibrogenesis. Semin Liver Dis 1990; 10: 30-46.
2. Gressner AM. Measurement connective tissue parameters in serum for diagnosis and follow-up of liver fibrosis. Ann Clin Biochem 1987; 24: (Pt 3):283-92.
3. Plebani M, Burlina A. Biochemical markers of hepatic fibrosis. Clin Biocbem 1991; 24:219-39.
4. Fraser JR, Laurent T, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronan injected intravenously in the rabbit. Biochem J 1981; 2000: 415-24.
5. Engstorm-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5: 638-42.
6. Nyberg A, Engstrome-Laurent A, Loof L. Serum hyaluronate in primary biliary cirrhosis: a biochemical marker for progressive liver damage. Hepatology 1988;8:152-6.
7. Alberti A, Morsica G, Chemello L, Cavaletto D, Noventa F, Pontisso P, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti HCV. Lancet 1992; 340: 697-8.
8. Wong V, Caronia S, Wight D, Britton P, Palmer C, Alexander G. Liver biopsy is essential in the management of patients with chronic hepatitis C virus infection. Gut 1995; 36:A949-A50.
9. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatitis 1998; 5:187-92.
10. Hamid S, Ismail FW, Jafri W. Hepatitis and the health care worker-a Pakistani perspective. J Coll Physicians Surg Pak 2007:17: 240-5.
11. Silva GF, Coelho KI, Nishimura NF, Soares EC. Progression of liver fibrosis in blood donors infected with hepatitis C virus. Rom J Gastroenterol 2004; 13: 291-7.
12. Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann intern Med 2002; 137: 961-4.
13. McHutchinson JG, Blatt LM, Medina M, Craig GR, Conrad A, Schiff ER, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. J Gastroenterol Hepatol 2000; 15: 945-51.
14. Bramley PN, Rathbone BJ, Forbes MA, Cooper EH, Losowsky MS. Serum hyaluronate as a marker of hepatic demngement in acute liver damage. J Hepatol 1991; 13: 8-13.
15. Plevris JN, Haydon GH, Simpson KJ, Dawkes R, Ludlum CA, Hardson DJ. Serum hyaluronan: a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12: 1121-7.
16. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowilz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in symptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
17. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24:399-403.
18. Xie S, Yao Zheng R, Peng X, Gao Z. Accurate diagnosis of stages of hepatic fibrosis by measuring levels of serum hyaluronic acid, procollagen type III, and collagen type IV, Zhongbua Gan Zang Bing Za Zazbi 2001; 9: 334-6.
19. Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001; 36: 399-406.
20. Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, et al. Non-invasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003; 37: 1220-1.
21. Oberti F, Valsesia E, Pillette C, Rousselet MC, Bedossa P, Aube C, et al. Non-invasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-16.
22. Ishibashi K, Kashiwagi T, Ito A, Tanaka Y, Nagasawa M, Toyama T, et al. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis C. Hepatology 1996; 24: 27-31.
23. Saracco, G, Rosina F, Abate ML, Chiandussi L, Gallo V, Ceruitti E, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon - alpha 2b. Hepatology 1993; 18: 1300-5.
24. Sobesky R, Mathurin P, Charlotte F. Moussalli J, Oliri M, Vidaud M, et al. Modelling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view. The Multivic Group. Gastroenterology 1999; 116: 378-86.